UNSPSC 51385807: Piroxicam cinnamate

This classification denotes a cyclooxygenase inhibitor with the molecular formula C24H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E8Q32N75N, chemically known as 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide, cinnamate (ester) but more generally known as piroxicam cinnamate, which bears US NIH Compound Identifier 6436090. European Medicines Agency schedules Piroxicam cinnamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14900MIG.

UNSPSC 51385807 Piroxicam cinnamate is a Commodity code with minimal recent relevant activity in state and local procurement. The three posted opportunities dating from early 2026 do not align with procurement of this specific anti-inflammatory pharmaceutical. Seminole County, Florida's IFB60459723LAS solicits naloxone and drug deactivation systems for community health, the Texas Health and Human Services Commission's RFI explores direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP covers generic multi-source pharmaceuticals and OTC products broadly — none target piroxicam cinnamate specifically. The mismatch between the code's nominal scope and the opportunities tagged to it suggests either miscoding at the issuing body level or minimal active procurement of this drug formulation through state and local channels during this period.

Opportunities in the block span Florida, Texas, and Minnesota through county health departments, state HHS agencies, and cooperative purchasing alliances, with response dates ranging from March 2026 through July 2026. The broader pharmaceutical and OTC category does see multi-jurisdictional activity through MMCAP's two-year cooperative contract model (effective July 1, 2026), but no issuer names piroxicam cinnamate as a line item or active procurement target. Firms pursuing this specific commodity should verify whether state and local formularies include piroxicam cinnamate in active purchasing or whether the code itself has been deprecated in favor of broader pharmaceutical family codes.